28888

    544319

    SENORES

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    SENORES PHARMACEUTICALS L Share Price Today

    SENORES PHARMACEUTICALS L is currently trading at ₹1314, up by ₹21.59 from the previous close. The stock touched an intraday high of ₹1325.00 and a low of ₹1293.60 during the latest trading session. Over the past one year, SENORES PHARMACEUTICALS L has delivered a return of 87.27%, while the stock has declined 0.09% in the last one month.

    SENORES PHARMACEUTICALS L performance

    Today’s low Today’s high
    ₹ 1293.60 ₹ 1325.00
    ₹ 1308.60
    52 week low 52 week high
    ₹ 632.05 ₹ 1509.80
    ₹ 1308.60
    Open Price ₹ 1298.90
    Prev. Close ₹ 1292.40
    Volume (Shares) 36252.00
    Total traded value ₹ 474.39
    Upper Circuit ₹ 1550.80
    Lower Circuit ₹ 1034.00
    info

    Investment Returns

    Over 1 Month -0.09% Over 3 Months 45.91% Over 6 Months 69.16% Over 1 Year 87.27%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    SENORES PHARMACEUTICALS L fundamentals


    • Market cap (Cr) 6,026.10
    • P/E Ratio (TTM) 319.79
    • Beta 0.97
    • Book Value / share 162.83
    • Return on equity 0.84%
    • EPS (TTM) 4.04
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 1.03
    info icon alternate text
    • Market cap (Cr) 6,034.40
    • P/E Ratio (TTM) 319.79
    • Beta 0.81
    • Book Value / share 162.83
    • Return on equity 0.84%
    • EPS (TTM) 4.04
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 1.03
    info icon alternate text

    SENORES PHARMACEUTICALS L Financials

    Open financial information
    Revenue
    Net income
    Particulars JUN 2026 (Values in Cr)
    Revenue 26.99
    Operating Expense 35.15
    Net Profit 1.03
    Net Profit Margin (%) 3.81
    Earnings Per Share (EPS) 0.22
    EBITDA 7.22
    Effective Tax Rate (%) 25.89
    Particulars MAR 2026 (Values in Cr)
    Revenue 36.81
    Operating Expense 46.31
    Net Profit 8.48
    Net Profit Margin (%) 23.03
    Earnings Per Share (EPS) 1.84
    EBITDA 18.71
    Effective Tax Rate (%) 33.17
    Particulars DEC 2025 (Values in Cr)
    Revenue 25.15
    Operating Expense 35.02
    Net Profit 2.65
    Net Profit Margin (%) 10.53
    Earnings Per Share (EPS) 1.98
    EBITDA 8.84
    Effective Tax Rate (%) 24.50
    Particulars SEP 2025 (Values in Cr)
    Revenue 20.92
    Operating Expense 39.04
    Net Profit 6.43
    Net Profit Margin (%) 30.73
    Earnings Per Share (EPS) 1.40
    EBITDA 12.88
    Effective Tax Rate (%) 15.94
    Particulars JUN 2025 (Values in Cr)
    Revenue 15.49
    Operating Expense 24.62
    Net Profit 2.70
    Net Profit Margin (%) 17.43
    Earnings Per Share (EPS) 0.59
    EBITDA 7.22
    Effective Tax Rate (%) 24.79
    Particulars MAR 2026 (Values in Cr)
    Revenue 106.09
    Operating Expense 144.98
    Net Profit 20.25
    Net Profit Margin (%) 19.08
    Earnings Per Share (EPS) 4.40
    EBITDA 47.67
    Effective Tax Rate (%) 26.25
    Particulars MAR 2025 (Values in Cr)
    Revenue 38.54
    Operating Expense 55.42
    Net Profit 3.69
    Net Profit Margin (%) 9.57
    Earnings Per Share (EPS) 1.02
    EBITDA 14.70
    Effective Tax Rate (%) 27.78
    Particulars MAR 2024 (Values in Cr)
    Revenue 34.01
    Operating Expense 38.83
    Net Profit 0.81
    Net Profit Margin (%) 2.38
    Earnings Per Share (EPS) 0.35
    EBITDA 6.78
    Effective Tax Rate (%) 60.09
    Particulars MAR 2023 (Values in Cr)
    Revenue 12.38
    Operating Expense 17.23
    Net Profit 1.20
    Net Profit Margin (%) 9.69
    Earnings Per Share (EPS) 1.26
    EBITDA 5.01
    Effective Tax Rate (%) 38.14
    Particulars MAR 2022 (Values in Cr)
    Revenue 15.85
    Operating Expense 15.98
    Net Profit 0.29
    Net Profit Margin (%) 1.82
    Earnings Per Share (EPS) 0.33
    EBITDA 1.97
    Effective Tax Rate (%) 67.77
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 170.72
    ROE % 11.78
    ROCE % 11.75
    Total Debt to Total Equity 0.58
    EBITDA Margin 27.36
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 66.95
    ROE % 26.19
    ROCE % 12.04
    Total Debt to Total Equity 1.28
    EBITDA Margin 20.70
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 46.36
    ROE % 20.54
    ROCE % 18.24
    Total Debt to Total Equity 0.94
    EBITDA Margin 46.29
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 41.86
    ROE % 2.71
    ROCE % 3.33
    Total Debt to Total Equity 0.40
    EBITDA Margin 17.08
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 153.74
    ROE % 0.84
    ROCE % 2.15
    Total Debt to Total Equity 0.23
    EBITDA Margin 38.17
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 55.10
    ROE % 0.78
    ROCE % 2.56
    Total Debt to Total Equity 0.78
    EBITDA Margin 19.94
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 39.66
    ROE % 3.30
    ROCE % 5.44
    Total Debt to Total Equity 1.04
    EBITDA Margin 40.47
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 38.54
    ROE % 3.15
    ROCE % 4.51
    Total Debt to Total Equity 0.43
    EBITDA Margin 15.51
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 24.91
    ROE % 8.87
    ROCE % 4.55
    Total Debt to Total Equity 0.39
    EBITDA Margin 14.79
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 385.50
    Total Assets 1226.86
    Total Liabilities 1226.86
    Total Equity 812.24
    Share Outstanding 4
    Price to Book Ratio 3.73
    Return on Assets (%) 4.77
    Return on Capital (%) 5.24
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 13.06
    Total Assets 621.88
    Total Liabilities 621.88
    Total Equity 231.71
    Share Outstanding 3
    Price to Book Ratio 0.00
    Return on Assets (%) 5.05
    Return on Capital (%) 6.55
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.10
    Total Assets 131.05
    Total Liabilities 131.05
    Total Equity 45.49
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 6.43
    Return on Capital (%) 7.94
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 3.21
    Total Assets 59.15
    Total Liabilities 59.15
    Total Equity 36.59
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 1.67
    Return on Capital (%) 1.95
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 359.72
    Total Assets 834.09
    Total Liabilities 834.09
    Total Equity 707.97
    Share Outstanding 4
    Price to Book Ratio 3.73
    Return on Assets (%) 0.44
    Return on Capital (%) 0.46
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 10.45
    Total Assets 285.86
    Total Liabilities 285.86
    Total Equity 168.12
    Share Outstanding 3
    Price to Book Ratio 0.00
    Return on Assets (%) 0.28
    Return on Capital (%) 0.31
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.09
    Total Assets 111.71
    Total Liabilities 111.71
    Total Equity 38.92
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 1.07
    Return on Capital (%) 1.21
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.40
    Total Assets 55.16
    Total Liabilities 55.16
    Total Equity 33.69
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 1.23
    Return on Capital (%) 1.42
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 1.64
    Total Assets 14.95
    Total Liabilities 14.95
    Total Equity 9.46
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 5.58
    Return on Capital (%) 6.35
    Particulars MAR 2025 (Values in Cr)
    Net Income 70.57
    Cash from Operations -36.75
    Cash from Investing -429.48
    Cash from Financing 573.13
    Net change in Cash 97.73
    Free Cash Flow 120.77
    Particulars MAR 2024 (Values in Cr)
    Net Income 24.94
    Cash from Operations -23.22
    Cash from Investing -54.23
    Cash from Financing 86.98
    Net change in Cash 7.05
    Free Cash Flow 28.61
    Particulars MAR 2023 (Values in Cr)
    Net Income 12.43
    Cash from Operations 0.37
    Cash from Investing -48.28
    Cash from Financing 46.25
    Net change in Cash -3.11
    Free Cash Flow 47.65
    Particulars MAR 2022 (Values in Cr)
    Net Income 1.14
    Cash from Operations -10.30
    Cash from Investing -24.44
    Cash from Financing 36.46
    Net change in Cash 1.57
    Free Cash Flow 0.37
    Particulars MAR 2025 (Values in Cr)
    Net Income 5.11
    Cash from Operations -18.95
    Cash from Investing -162.94
    Cash from Financing 532.62
    Net change in Cash 349.28
    Free Cash Flow 30.16
    Particulars MAR 2024 (Values in Cr)
    Net Income 2.03
    Cash from Operations -18.07
    Cash from Investing -57.07
    Cash from Financing 86.68
    Net change in Cash 10.35
    Free Cash Flow 1.19
    Particulars MAR 2023 (Values in Cr)
    Net Income 1.94
    Cash from Operations -39.80
    Cash from Investing -5.22
    Cash from Financing 47.07
    Net change in Cash -1.56
    Free Cash Flow -31.42
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.83
    Cash from Operations -23.91
    Cash from Investing -10.05
    Cash from Financing 33.87
    Net change in Cash -0.23
    Free Cash Flow -23.43
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.40
    Cash from Operations -2.85
    Cash from Investing -4.37
    Cash from Financing 8.49
    Net change in Cash 1.25
    Free Cash Flow -0.06
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.89 12.82 1.49 236.72 23.12 38.85
    BLISS GVS PHARMA LTD. 458.05 36.82 4.07 4857.91 118.35 552.90
    CIPLA LTD 1473.45 33.26 3.45 119031.97 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 451.45 21.12 3.26 1328.66 256.40 480.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.89 21.60 3.97 236.72 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 516.80 23.16 4.03 1494.10 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8179.35 106.89 23.42 20448.38 7630.00 9850.00
    BLISS GVS PHARMA LTD. 458.05 49.52 4.20 4857.91 118.35 552.90

    SENORES PHARMACEUTICALS L shareholding pattern

    Holding
    37.79%
    45.81%
    6.61%
    9.77%
    2.81%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    SENORES PHARMACEUTICALS L Technicals Summary

    1308.50 1.24 redarrow
    red-green-graph indicator
    10 Bearish
    6 Bullish
    • 5 Days 1335.90
    • 26 Days 1346.90
    • 10 Days 1360.60
    • 50 Days 1267.10
    • 12 Days 1364.60
    • 100 Days 1130.10
    • 20 Days 1361.00
    • 200 Days 974.60
    1324.27 PIVOT
    First Support 1304.03 First Resistance 1338.53 Second Support 1289.77 Second Resistance 1358.77 Third Support 1269.53 Third Resistance 1373.03
    RSI 45.35 ADX 20.99 MACD 26.49 Williams % R -86.30 Commodity Channel Index (CCI) -149.56
    Date 2026-07-29 Week 156550.00 Same Day 80394.00 Month 124067.00
    1 Year 0.98 3 Year 1.17
    Over 1 Month
    -0.09% down
    Over 1 Year
    87.27% down
    Over 3 Months
    45.91% down
    Over 3 Years
    0.00% down
    Over 6 Months
    69.16% down
    Over 5 Years
    0.00% down

    SENORES PHARMACEUTICALS L Corporate Actions

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Senores Pharmaceuticals Ltd?

    Answer Field

    Senores Pharmaceuticals Ltd share price is for NSE ₹ 1,314.00 & for BSE ₹ 1,315.30 as on Jul 31 2026 11:43 AM.

    What is the Market Cap of Senores Pharmaceuticals Ltd Share?

    Answer Field

    The market cap of Senores Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 31 2026 11:43 AM.

    What is the 52 Week High and Low of Senores Pharmaceuticals Ltd?

    Answer Field

    The 52 Week High and Low of Senores Pharmaceuticals Ltd for NSE is ₹ 1,509.80 and ₹ 632.05 and for BSE is ₹ 1,509.20 and ₹ 632.50.

    What is 1 year return for Senores Pharmaceuticals Ltd?

    Answer Field

    The 1 year returns on the stock has been 85.30%.

    What is the P/E Ratio of Senores Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 31 2026 11:43 AM the price-to-earnings (PE) ratio for Senores Pharmaceuticals Ltd share is 319.79.

    What is the PB ratio of Senores Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 31 2026 11:43 AM, the price-to-book (PB) ratio for Senores Pharmaceuticals Ltd share is 162.83.

    How to Buy Senores Pharmaceuticals Ltd Share?

    Answer Field

    You can trade in Senores Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Senores Pharmaceuticals Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Senores Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Senores Pharmaceuticals Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |